CH FRONTIER TEC (01661) will be temporarily suspended from trading starting April 1st morning pending the publication of its full-year 2024 performance.

01/04/2025

GMT Eight

CH FRONTIER TEC (01661) announced that the company will postpone the publication of its full-year performance in 2024 and delay the holding of the board meeting. At the request of the company, trading of the company's shares on the Stock Exchange will be suspended from 9:00 am on April 1, 2025, until the publication of the full-year performance in 2024.

IMMUNEONCO-B(01541): The Phase II clinical trial of IMM2510 for pleuropulmonary soft tissue sarcoma has completed the first subject's enrollment and medication.

No more content

Contact: [email protected]

CH FRONTIER TEC (01661) will be temporarily suspended from trading starting April 1st morning pending the publication of its full-year 2024 performance.

RECOMMEND

US Stock Market Move | Most new energy vehicle stocks are falling, with Rivian (RIVN.US) dropping more than 5%.

US Stock Market Move | Faraday Future Intelligent Electric, Inc. (FFAI.US) rose more than 3% and released the design of the front face of its first model, FX.

US Stock Market Move | Tesla, Inc. (TSLA.US) erases an initial drop of over 6% and is now up over 2%.